Company Profile
Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”, listed on the Hong Kong Stock Exchange, stock code: 0455) implements the following development strategies: development of Traditional Chinese medicine (“TCM”) as its foundation, development of innovative drugs and medical technologies, as well as development of high-quality medical and healthcare services. It is committed to becoming a competitive pharmaceutical enterprise and core value chain in pharmaceuticals, medical technology, TCM treatment and health management.
Tianda Pharmaceuticals forges the entire TCM industrial chain from Chinese medicine, Chinese Medicinal herbs to the application of artificial intelligence in TCM. It has established the "Tianda standard", a Chinese medicinal herbs quality control standard, and the modern Chinese medicine clinic - TDMall. As a TCM treatment and health management platform, TDMall practices TCM by adhering to the philosophy that “a great physician treats an illness before it develops”, following the treatment principle of “medication should be stopped once its efficacy shows and treatment should be centred on the patient”. Based in the Guangdong-Hong Kong-Macau Greater Bay Area, TDMall applies domestic and international strategic business plan and strives to develop into the leading brand of Chinese medicine clinic. Making full use of Internet information technology, big data, artificial intelligence and other innovative technologies, Tianda Pharmaceuticals has built "TDMall on Cloud" to implement the integration of online and offline TCM services, remote diagnosis and treatment and expert consultation, which provides a high-quality, convenient and comprehensive TCM health services for the general public, becoming a forerunner in the promotion of TCM inheritance, innovation and development.

Latest News
Press Releases
-
28.08.2023
Tianda Pharmaceuticals’ Financial Results for the Six Months Ende ...
Press Releases
-
06.07.2023
Tianda Pharmaceuticals’ Tuoen® Ibuprofen Awarded as the Most Valu ...
Press Releases
-
15.06.2023
Tianda Pharmaceuticals Showcases Cutting-edge Products Tuokang® ...
Sustainability Strategy
-
12.05.2023
Tianda Group & Tianda Pharmaceuticals were awarded the “Happy Com ...
Press Releases
-
14.04.2023
Tianda Chinese Medicine Limited Promoted TCM Industry- Academia-R ...
Press Releases
-
29.03.2023
Grand Opening of Shenzhen TDMall with the Launch of “TDMall Lifes ...
Press Releases
-
23.03.2023
Tianda Pharma Announces Results for the Nine Months Ended 31 Dece ...
Sustainability Strategy
-
01.03.2023
Tianda Pharmaceuticals awarded “Caring Company” Logo for three co ...
Tianda for Health!


T i a n d a f o r H e a l t h !
Core Business
Achievements




Shares and Details
Announcements & Circulars
-
20.09.2023
Announcements and Notices - [Continuing Connected Transaction] (I) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH SPH AND (II) RENEWAL OF FRAMEWORK AGREEMENT WITH SPH
- 04.09.2023
-
29.08.2023
Announcements and Notices - [List of Directors and their Role and Function] LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION